Riskpilot← Back to searchSign inGet full accessHestepraksisNord ApS
APSActiveCVR 40067574Skagensvej 195CVeterinary activities · NACE 7500Est. 201812 employeeswww.hestepraksisnord.dk
Revenue 2025
DKK 5,5M
+352% vs 2024
EBITDA margin
0.7%
-46% vs 2024
Equity ratio
-15.2%
Financial strength
Net profit 2025
DKK -597K
-719% vs 2024
| Revenue | DKK 5,5M | +352% |
| EBITDA | DKK 41K | -46% |
| Net profit | DKK -597K | -719% |
| Total assets | DKK 7,2M | +510% |
| Equity | DKK -1,1M | -121% |
| Employees | 12 | — |
Legal name
HestepraksisNord ApS
CVR number
40067574
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
4. december 2018
Share capital
DKK 50.000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion i forening.
Company purpose
Selskabets formål er at drive dyrlægevirksomhed og dermed beslægtet virksomhed.
Address
Skagensvej 195C
Phone
+4573708165
Email
info@hestepraksisnord.dk
Website
www.hestepraksisnord.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.864 | 2.406 | 2.395 | 1.208 | 5.462 |
| Staff expenses | -2.106 | -2.514 | -1.988 | -1.113 | -5.421 |
| EBITDA | -242 | -127 | 408 | 75 | 41 |
| Depreciation & amort. | -66 | -185 | -179 | -88 | -573 |
| EBIT | -308 | -312 | 229 | -13 | -533 |
| Net financials | -20 | -80 | -108 | -34 | -231 |
| Profit before tax | -328 | -392 | 121 | -47 | -764 |
| Tax | -73 | 74 | -0 | -143 | -166 |
| Net profit | -255 | -465 | 121 | 96 | -597 |
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.558 | 1.231 | 1.022 | 1.177 | 7.186 |
| Equity | -244 | -710 | -589 | -493 | -1.090 |
| Long-term debt | 178 | 0 | 187 | 0 | 0 |
| Short-term debt | 1.625 | 1.941 | 1.424 | 1.670 | 8.276 |
| Total debt | 1.803 | 1.941 | 1.611 | 1.670 | 8.276 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20222025
Equity ratio
-15.2%
This company
38.2%
Market median
-140% vs market
20222025
Return on equity
-59709300.0%
This company
18.4%
Market median
-324507165% vs market
20222025
Net profit margin
-10.9%
This company
8.1%
Market median
-235% vs market
20222025
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20222025
Debt / equity
7.59×
This company
0.62×
Market median
-1124% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-07-01 – 2024-12-31
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
EP Management | Management | 2019 |
MM Management | Management | 2021 |
NN Founder | Founder | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Deputy Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 50–66.65% | 50–66.65% | 2019 | |
| Company | 50–66.65% | 50–66.65% | 2019 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Altano Denmark A/S
HestepraksisNord ApS Board members of HestepraksisNord ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elisabeth Pontoppidan | Management | 0 companies |
| Mette Marie Rauer Larsen | Management | 0 companies |
| Nanna Nørholm Henriksen | Founder | 0 companies |
| Michael Baastrup Munk | Chairman | 0 companies |
| Helle Nørgaard Andreasen | Deputy Chairman | 0 companies |